Home
Market Capitalization of Indoco Remedies Ltd

Indoco Remedies Ltd
NSE: INDOCO
Market Cap
Key Highlights
- The Market Cap of Indoco Remedies Ltd is ₹ 2144 crore as of 30 Apr 25 .
- The Latest Trading Price of Indoco Remedies Ltd is ₹ 232.5 as of 30 Apr 15:30 .
- The dividend payouts of Indoco Remedies Ltd changed from ₹ 1.5 to ₹ 0.3 over 6 quarters. This represents a CAGR of -65.80% .

Indoco Remedies Ltd
NSE: INDOCO
Share Price
Market Price of Indoco Remedies Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
30 Apr 2025 | 232.5 |
29 Apr 2025 | 226.65 |
28 Apr 2025 | 231.05 |
25 Apr 2025 | 232.15 |
24 Apr 2025 | 238.9 |
23 Apr 2025 | 240.95 |
22 Apr 2025 | 246.15 |
21 Apr 2025 | 242.15 |
17 Apr 2025 | 239.25 |
16 Apr 2025 | 239.95 |
SWOT Analysis Of Indoco Remedies Ltd
BlinkX Score for Indoco Remedies Ltd
Asset Value vs Market Value of Indoco Remedies Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Indoco Remedies Ltd
Historical P/E Ratio of Indoco Remedies Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Indoco Remedies Ltd
Historical Revenue of Indoco Remedies Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Indoco Remedies Ltd
Historical EBITDA of Indoco Remedies Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Indoco Remedies Ltd
Historical Net Profit of Indoco Remedies Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Indoco Remedies Ltd
Historical Dividend Payouts of Indoco Remedies Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Indoco Remedies Ltd
About Indoco Remedies Ltd
- Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
- The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
- The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.
Indoco Remedies Ltd News Hub
Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg
Indoco Remedies announced the receipt of final approval from the USFDA for Abbreviated New Drug Appl
Read more
21 Aug 24
Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets
The generic equivalent of Lucemyra Tablets will market to USWM, LLC. 'Indoco has been granted a Comp
Read more
21 Aug 24
Indoco Remedies fixes record date for final dividend
Indoco Remedies has fixed 19 September 2024 as record date for determining entitlement of members to
Read more
30 Aug 24
Indoco Remedies AGM scheduled
Indoco Remedies announced that the Annual General Meeting (AGM) of the company will be held on 26 Se
Read more
31 Aug 24